Association between prehypertension and chronic kidney disease in the Japanese general population

Kidney International

Volumn 81, Issue 3, 2012, Pages 293-299

  Yano, Yuichiro ^a   Fujimoto, Shouichi ^b   Sato, Yuji ^a   Konta, Tsuneo ^c   Iseki, Kunitoshi ^d   Moriyama, Toshiki ^d   Yamagata, Kunihiro ^d   Tsuruya, Kazuhiko ^d   Yoshida, Hideaki ^d   Asahi, Koichi ^d   Kurahashi, Issei ^e   Ohashi, Yasuo ^e   Watanabe, Tsuyoshi ^d  

^a UNIVERSITY OF MIYAZAKI   (Japan)

^b UNIVERSITY OF MIYAZAKI HOSPITAL   (Japan)

^c YAMAGATA UNIVERSITY   (Japan)

^d Steering Comm Res Positioning Chron Kidney Dis Specific Hlth Check Guid Japan   (Japan)

^e UNIVERSITY OF TOKYO   (Japan)

Author keywords

chronic kidney disease; high normal blood pressure; obesity; prehypertension

Indexed keywords

ADULT; ARTICLE; BLOOD PRESSURE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DATA BASE; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; JAPANESE; MAJOR CLINICAL STUDY; MALE; OBESITY; PATIENT CODING; PREHYPERTENSION; PREVALENCE; PRIORITY JOURNAL; PROTEINURIA; RISK ASSESSMENT; RISK FACTOR;

EID: 84856711032     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2011.346     Document Type: Article

References (36)

1. Levey AS, Atkins R, Coresh J et al. Chronic kidney disease as a global public health problem: approaches and initiatives-a position statement from Kidney Disease Improving Global Outcomes. Kidney Int 2007; 72: 247-259. (Pubitemid 47172384)
2. Schiffrin EL, Lipman ML, Mann JF. Chronic kidney disease: effects on the cardiovascular system. Circulation 2007; 116: 85-97. (Pubitemid 47016250)
3. Imai E, Horio M, Watanabe T et al. Prevalence of chronic kidney disease in the Japanese general population. Clin Exp Nephrol 2009; 13: 621-630.
4. Hall YN, Hsu CY, Iribarren C et al. The conundrum of increased burden of end-stage renal disease in Asians. Kidney Int 2005; 68: 2310-2316. (Pubitemid 43117809)
5. Nagata M, Ninomiya T, Doi Y et al. Trends in the prevalence of chronic kidney disease and its risk factors in a general Japanese population: the Hisayama Study. Nephrol Dial Transplant 2010; 25: 2557-2564.
6. Nakai S, Masakane I, Akiba T et al. Overview of regular dialysis treatment in Japan as of 31 December 2006. Ther Apher Dial 2008; 12: 428-456.
7. Imai E, Matsuo S, Makino H et al. Chronic Kidney Disease Japan Cohort study: baseline characteristics and factors associated with causative diseases and renal function. Clin Exp Nephrol 2010; 14: 558-570.
8. Iseki K, Iseki C, Ikemiya Y et al. Risk of developing end-stage renal disease in a cohort of mass screening. Kidney Int 1996; 49: 800-805. (Pubitemid 26093091)
9. Iseki K. Gender differences in chronic kidney disease. Kidney Int 2008; 74: 415-417.
10. O'Seaghdha CM, Perkovic V, Lam TH et al. Blood pressure is a major risk factor for renal death: an analysis of 560 352 participants from the Asia-Pacific region. Hypertension 2009; 54: 509-515.
11. Iseki K, Ikemiya Y, Kinjo K et al. Body mass index and the risk of development of end-stage renal disease in a screened cohort. Kidney Int 2004; 65: 1870-1876. (Pubitemid 38591038)
12. Yamagata K, Ishida K, Sairenchi T et al. Risk factors for chronic kidney disease in a community-based population: a 10-year follow-up study. Kidney Int 2007; 71: 159-166. (Pubitemid 46094690)
13. Kiberd B. The chronic kidney disease epidemic: stepping back and looking forward. J Am Soc Nephrol 2006; 17: 2967-2973. (Pubitemid 44707756)
14. Crews DC, Plantinga LC, Miller 3rd ER et al. Prevalence of chronic kidney disease in persons with undiagnosed or prehypertension in the United States. Hypertension 2010; 55: 1102-1109.
15. Pimenta E, Oparil S. Medscape. Prehypertension: epidemiology, consequences and treatment. Nat Rev Nephrol 2001; 6: 21-30.
16. Ishikawa Y, Ishikawa J, Ishikawa S et al. Prehypertension and the risk for cardiovascular disease in the Japanese general population: the Jichi Medical School Cohort Study. J Hypertens 2010; 28: 1630-1637.
17. Kalaitzidis RG, Bakris GL. Prehypertension: is it relevant for nephrologists? Kidney Int 2010; 77: 194-200.
18. Ninomiya T, Kubo M, Doi Y et al. Prehypertension increases the risk for renal arteriosclerosis in autopsies: the Hisayama Study. J Am Soc Nephrol 2007; 18: 2135-2142. (Pubitemid 47041079)
19. Iseki K, Iseki C, Ikemiya Y et al. Risk of developing end-stage renal disease in a cohort of mass screening. Kidney Int 1996; 49: 800-805. (Pubitemid 26093091)
20. Tanaka T, Okamura T, Yamagata Z et al. Awareness and treatment of hypertension and hypercholesterolemia in Japanese workers: the High-risk and Population Strategy for Occupational Health Promotion (HIPOP-OHP) study. Hypertens Res 2007; 30: 921-928. (Pubitemid 350120969)
21. Wahba IM, Mak RH. Obesity and obesity-initiated metabolic syndrome: mechanistic links to chronic kidney disease. Clin J Am Soc Nephrol 2007; 2: 550-562.
22. Guarnieri G, Zanetti M, Vinci P et al. Metabolic syndrome and chronic kidney disease. J Ren Nutr 2010; 20(5 Suppl): S19-S23.
23. Wisse BE. The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity. J Am Soc Nephrol 2004; 15: 2792-2800. (Pubitemid 41103388)
24. Ribstein J, du Cailar G, Mimran A. Combined renal effects of overweight and hypertension. Hypertension 1995; 26: 610-615.
25. Krikken JA, Bakker SJ, Navis GJ. Role of renal haemodynamics in the renal risks of overweight. Nephrol Dial Transplant 2009; 24: 1708-1711.
26. Appel LJ. Lifestyle modification as a means to prevent and treat high blood pressure. J Am Soc Nephrol 2003; 14(7 Suppl 2): S99-S102. (Pubitemid 36750501)
27. Ishizaka N, Ishizaka Y, Toda E et al. Association between cigarette smoking and chronic kidney disease in Japanese men. Hypertens Res 2008; 31: 485-492. (Pubitemid 351597502)
28. Orth SR. Effects of smoking on systemic and intrarenal hemodynamics: influence on renal function. J Am Soc Nephrol 2004; 15(Suppl 1): S58-S63. (Pubitemid 38018458)
29. Sauriasari R, Sakano N, Wang DH et al. C-reactive protein is associated with cigarette smoking-induced hyperfiltration and proteinuria in an apparently healthy population. Hypertens Res 2010; 33: 1129-1136.
30. Shankar A, Klein R, Klein BE. The association among smoking, heavy drinking, and chronic kidney disease. Am J Epidemiol 2006; 164: 263-271. (Pubitemid 44289047)
31. Mann SJ, James GD, Wang RS et al. Elevation of ambulatory systolic blood pressure in hypertensive smokers. A case-control study. JAMA 1991; 265: 2226-2228.
32. Chobanian AV, Bakris GL, Black HR et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 2003; 289: 2560-2572. (Pubitemid 37430158)
33. Ogihara T, Kikuchi K, Matsuoka H et al. The Japanese society of hypertension guidelines for the management of hypertension (JSH 2009). Hypertens Res 2009; 32: 3-107.
34. Examination Committee of Criteria for 'Obesity Disease' in Japan; Japan Society for the Study of Obesity. New criteria for 'obesity disease' in Japan. Circ J 2002; 66: 987-992.
35. Matsuo S, Imai E, Horio M et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009; 53: 982-992.
36. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39(2 Suppl 1): S1-S266.